Mednet Logo
SpecialtiesNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

What is your preferred first-line treatment for chronic fatigue in patients with long COVID-19?

8
9 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Assuming that a thorough workup for other causes of fatigue (anemia, thyroid dysfunction, sleep apnea, etc.) has been performed and is negative, no single medication has been proven by a randomized placebo-controlled trial to help chronic fatigue in PASC. Anecdotally, my colleagues who treat PASC ha...

How do you approach evaluating the hemorrhage risk of restarting anticoagulation in a patient with ischemic stroke and infective endocarditis without access to DSA?

2
2 Answers

Mednet Member
Mednet Member
Neurology · NYU

This is a really excellent question. First of all, if the patient has infective endocarditis, they really should undergo appropriate antibiotic treatment prior to initiating anticoagulation. I have seen several patients have significant (and in some cases fatal) hemorrhages because anticoagulation w...

When do you use anticoagulation over antiplatelet therapy for secondary stroke prevention in patients with LV injury or dysfunction?

1
1 Answers

Mednet Member
Mednet Member
Neurology · University of Calgary

First, I will observe that the recent work is a cohort study, not an RCT< and I would be careful about concluding that anticoagulation is the best approach. We have had prior trials, e.g., WARCEF and the related ESUS trials (NAVIGATE and RESPECT), and others that have looked at possible cardioemboli...

What are your top takeaways from AHS 2026 Scientific Session?

1 Answers

Mednet Member
Mednet Member
Neurology · The University of Texas At Austin Dell Medical School

1. Earlier, phenotype-driven treatment of post-traumatic headache (PTH) is gaining momentum. Early treatment of post-traumatic headache using both acute and preventive strategies is increasingly favored, with management tailored to headache phenotype and risk factors for persistence. Nutraceuticals ...

How do you manage patients with chronic migraine as well as medication overuse headaches?

3
6 Answers

Mednet Member
Mednet Member
Neurology · UCLA

I agree with Dr. @Dr. First Last about the treatment for chronic migraine and MOH for patients on opiates and/or barbiturates. If they are taking frequent opiates, I prefer to have a pain management doctor detoxify them. In the past, I slowly decreased their medication while giving them long-acting ...

How do you counsel patients and caregivers about the trajectory of cognitive decline in Parkinson’s disease?

1
3 Answers

Mednet Member
Mednet Member
Neurology · Keck School of Medicine of USC

I address the subject of cognitive impairment fairly early in PD, since patients may notice mild deficits in multitasking and attention even within the first few years of diagnosis. Strategies such as making lists and breaking down individual tasks are effective in preserving independence. Worsening...

What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?

5
1 Answers

Mednet Member
Mednet Member
Rheumatology · Emory University School of Medicine

Inebilizumab may play an important role in the maintenance treatment of IgG4-related disease (IgG4-RD), particularly in patients at high risk for relapse. These are typically patients with multi-organ involvement and elevated serum IgG4 levels who initially respond well to corticosteroids but tend t...

When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?

10
1 Answers

Mednet Member
Mednet Member
Psychiatry · University of Washington

Cholinesterase inhibitors should be given to all patients (unless there is a contraindication) with Alzheimer's dementia since this class slows cognitive and functional decline as well as reduces all-cause mortality. Memantine, an NMDA receptor antagonist, is only FDA-approved for moderate to severe...

In patients with medically-refractory left temporal epilepsy, and left dominant language and memory, how should you approach surgical intervention?

2 Answers

Mednet Member
Mednet Member
Neurology · University of Rochester Medical Center

The approach is tailored to the individual patient and their particular case. If the neuropsychological profile suggests they have significant deficits already in verbal memory, then the risk is usually not as significant for them to notice a clinically meaningful post-surgical decline as it is for ...

What are your preferred second-line medications for trigeminal neuralgia?

1
4 Answers

Mednet Member
Mednet Member
Neurology · UPMC

My first line is oxcarbazepine or carbamazepine. The second line is gabapentin. Then, in no particular order, baclofen and lamotrigine. Other options to try: pimozide, tizanidine, phenytoin, valproic acid. If 1 agent does not provide good control, I refer to a surgeon as we try a 2nd agent.